Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Although generic drugs are pharmacologically equivalent to their brand-name counterparts, prejudices against the former remain strong among patients and doctors. In a randomized controlled field experiment, this research assesses the extent to which generic (versus brand-name) labels affect patients' consumption dosage, medication compliance and reported pain.
One hundred one patients scheduled to undergo invasive dental surgeries (i.e., dental implants) participated in the experiment. After dental surgery, patients were prescribed a once-daily analgesic regimen for up to 7 days. The intervention consisted of label manipulation. Patients were randomly assigned to either the brand-name analgesic or to its (purportedly) cheaper generic version. In reality, all participants obtained the same brand-name medication. The medication was provided at no cost, and patients were instructed to take the first pill while at the clinic. They were informed that they could (a) increase the dosage of the prescribed analgesic to twice daily if necessary and (b) stop taking the medication when no longer needed. Any other changes to the regimen were discouraged, and patients were instructed to consult with the dentist before any such changes. Telephone follow-ups were conducted at 24 hours, 4 days, and 7 days after surgery. Two main dependent variables were obtained: the number of prescribed analgesics consumed and the number of non-prescribed analgesics consumed. The patients also reported the pain felt during the period.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Generic Label | Experimental | Purportedly generic version of the analgesic presented |
|
| Brand-name Label | Active Comparator | actual brand-name analgesic presented |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Label | Other | Participants were presented with either a generic label or a brand-name label |
|
| Measure | Description | Time Frame |
|---|---|---|
| Non-Compliance | Number of patients who consumed at least one non-prescribed analgesic pill during the first 24 hours | 1 day after the intervention |
| Non-Compliance | Number of patients who consumed at least one non-prescribed analgesic pill during the period (from day 2 to day 4) | 4 days after the intervention |
| Non-compliance | Number of patients who consumed at least one non-prescribed analgesic pill during the period (from day 5 to day 7) | 7 days after the intervention |
| Measure | Description | Time Frame |
|---|---|---|
| Consumption Dosage | Average number of pills consumed during the study period (first 24 hours) | 1 day after the intervention |
| Consumption Dosage | Average number of pills consumed during the study period (from day 2 to day 4) |
| Measure | Description | Time Frame |
|---|---|---|
| Pain levels | Average retrospective and current level of pain; eleven-point scale (0=not at all, 10=extreme) | 1 day after the intervention |
| Pain levels | Average retrospective and current level of pain; eleven-point scale (0=not at all, 10=extreme) |
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D004348 | Drug Labeling |
| ID | Term |
|---|---|
| D013678 | Technology, Pharmaceutical |
| D008919 | Investigative Techniques |
| D004349 | Drug Packaging |
| D004345 | Drug Industry |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| 4 days after the intervention |
| Consumption dosage | Average number of pills consumed during the study period (from day 5 to 7) | 7 days after the intervention |
| 4 days after the intervention |
| Pain levels | Average retrospective and current level of pain; eleven-point scale (0=not at all, 10=extreme) | 7 days after the intervention |
| Perceived Efficacy | perceived efficacy of prescribed painkiller (0=It does not reduce pain at all; 10=it eliminates pain completely) | 1 day after the intervention |
| Perceived Efficacy | perceived efficacy of prescribed painkiller (0=It does not reduce pain at all; 10=it eliminates pain completely) | 4 days after the intervention |
| Perceived Efficacy | perceived efficacy of prescribed painkiller (0=It does not reduce pain at all; 10=it eliminates pain completely) | 7 days after the intervention |
| Referral | the likelihood of indicating it a friend (0=Never; 10=Certainly). | 1 day after the intervention |
| referral | the likelihood of indicating it a friend (0=Never; 10=Certainly). | 4 days after the intervention |
| referral | the likelihood of indicating it a friend (0=Never; 10=Certainly). | 7 days after the intervention |
| D066192 |
| Manufacturing Industry |
| D007221 | Industry |
| D013676 | Technology, Industry, and Agriculture |
| D019064 | Product Packaging |